# OnCo record ovarian-function-after-chemotherapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/ovarian-function-after-chemotherapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "ovarian-function-after-chemotherapy" ;
  schema:name "Ovarian function after chemotherapy: who recovers, and when"@en ;
  schema:description "Whether periods return after chemotherapy depends mostly on age and on which drugs were given. In the one study that recorded bleeding daily, about two thirds of women who stopped bleeding for six months after an anthracycline regimen started again, usually within a year. Of those who went two years without a period, one in ten bled again and none regained regular cycles."@en ;
  schema:url <https://onco.cc/technologies/ovarian-function-after-chemotherapy/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Premature_ovarian_failure> ;
  schema:citation <https://doi.org/10.1056/NEJMoa1413204>, <https://doi.org/10.1200/JCO.2018.78.0858>, <https://doi.org/10.1200/JCO.2005.03.3969>, <https://doi.org/10.1002/cncr.25106>, <https://doi.org/10.1200/JCO.2018.78.1914> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "evidence:moderate" ;
  onco:related <https://onco.cc/ideas/idea-acc-default-fertility-preservation-referral/>, <https://onco.cc/ideas/idea-moon-fertility-preservation-default/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:technologies <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/menopause-after-cancer-treatment/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/cancer-treatment-bone-loss/> ;
  onco:drugs <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/goserelin/>, <https://onco.cc/drugs/leuprolide/>, <https://onco.cc/drugs/tamoxifen/> ;
  onco:terms <https://onco.cc/terms/ovarian-function-suppression/>, <https://onco.cc/terms/menopause-after-chemotherapy-breast/>, <https://onco.cc/terms/aya-oncology/>, <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .